RxDoctor Payments Data

Nicolette Alexander, NP

Family · Michigan City, INNPI 1437347358

Payments from drug & device makers

$274in general payments, 2019–2025

Across 14 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$98
  • Dexcom, Inc.$45
  • Astellas Pharma US Inc$43
  • Pfizer$24
  • Takeda Pharmaceuticals U.S.A., Inc.$17
  • Abbott$16
  • plus $31 from 2 others

What the payments were for

  • Food & beverage$274100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$274 in reported general payments places this provider in the 40th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$87,191
Medicare patients
272
Services billed
1,307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide49$54,038
EliquisApixaban38$43,151
OzempicSemaglutide13$24,466
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$23,712
TradjentaLinagliptin16$22,810
JardianceEmpagliflozin20$18,263
JanuviaSitagliptin Phosphate14$15,125
MyrbetriqMirabegron11$14,926
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$10,346
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$3,910
Atorvastatin Calcium595$3,675
Aripiprazole50$2,928
SymbicortBudesonide/Formoterol Fumarate11$2,903
SynthroidLevothyroxine Sodium25$2,311
Testosterone17$2,011

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$24$43,15138 claims
Novo NordiskOzempic$98$24,46613 claims
Astellas Pharma US IncMyrbetriq$43$14,92611 claims
AbbVieSynthroid$15$2,31125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 4,392 family providers in Indiana.

Other family in Michigan City

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →